Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
about
Cardiac cachexia: hic et nuncCrosstalk between the heart and peripheral organs in heart failureBiomarkers for physical frailty and sarcopenia: state of the science and future developmentsSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingRegulation of satellite cell function in sarcopeniaInsights into muscle degeneration from heritable inclusion body myopathiesC. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation.Melatonin as a Potential Agent in the Treatment of SarcopeniaRedox signaling in skeletal muscle: role of aging and exerciseMitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged ratsCell death, clearance and immunity in the skeletal muscleEffects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseEpidemiology of sarcopenia and insight into possible therapeutic targets.SIRT1 is required for mitochondrial biogenesis reprogramming in hypoxic human pulmonary arteriolar smooth muscle cells.Association of Coffee Consumption with Sarcopenia in Korean Elderly Men: Analysis Using the Korea National Health and Nutrition Examination Survey, 2008-2011.Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue.Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α.Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory studyAge-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseasesMuscle wasting: an overview of recent developments in basic research.Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment.REDD2 expression in rat skeletal muscle correlates with nutrient-induced activation of mTORC1: responses to aging, immobilization, and remobilization.Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and functionSignaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cellsMDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361.Mitochondrial maintenance failure in aging and role of sexual dimorphism.Programmed cell death in aging.Impaired mitochondrial degradation by autophagy in the skeletal muscle of the aged female interleukin 10 null mouse.Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease.Editorial: Pathophysiological Mechanisms of Sarcopenia in Aging and in Muscular Dystrophy: A Translational Approach.Ablation of S1P3 receptor protects mouse soleus from age-related drop in muscle mass, force, and regenerative capacity.Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study.Hypertension and aging.An analysis of age-related loss of skeletal muscle mass and its significance on osteoarthritis in a Korean populationThe association of physical activity and cholesterol concentrations across different combinations of central adiposity and body mass index.Exercise Promotes Healthy Aging of Skeletal MuscleIntraoperative hemidiaphragm electrical stimulation reduces oxidative stress and upregulates autophagy in surgery patients undergoing mechanical ventilation: exploratory study.Poor maternal nutrition and accelerated postnatal growth induces an accelerated aging phenotype and oxidative stress in skeletal muscle of male rats.
P2860
Q26744140-175243ED-757E-47FC-92FB-B90C3CB49496Q26766491-8727DB88-26A0-4B74-9B6E-5F4D29E42002Q26775328-7D786033-00AC-4541-A295-C13E409E66DDQ26781640-CDA01BF7-C740-41E0-9E1F-638DD38D6192Q26826890-E3AE361E-F954-4925-90D7-3FE065DA002BQ26851967-E0A82976-6337-4CED-AFF7-6E6A2854FCF1Q27317960-04A2BB6F-8F13-4CCD-84E2-B40C7DA3B991Q28076649-AF7A9EEB-535D-4701-946F-C21F83F187CFQ28088635-F1C2B9C8-7943-4BC4-84C0-03D5124284EBQ28385949-5487C8E7-0C66-4CF1-B032-1DEC2EA875EFQ28386837-64DAABD5-FB27-421D-BB5C-1B0897F37988Q28606560-F1AF2165-EA9C-451B-B799-B944C641D98CQ30234579-C77E091E-F0BE-4D9C-8A89-EE4381C44D1BQ33598955-4C5B89F4-148D-4F56-836A-EF86608F19F4Q33747124-89D5A330-4E0A-4841-A0BC-2B75B51BA606Q33813591-C5AF2161-0303-4C50-95A6-AC8410B40517Q33816700-47F4BC19-80B8-4C49-85F1-EB834C056A36Q33901304-E1AE4FFF-7B82-424B-BF2D-2D0F54E88AC1Q34102906-9E23D17B-90DA-4AA7-8233-3F7E4DA660C4Q34145591-3F138F83-E1D8-4DBA-B23B-06288AE42EBCQ34156942-58ABDD2E-FCAD-4CFD-A323-F9E93A08B4DCQ34299706-B1600BE0-8785-468F-9B35-2E009C9D0FA0Q34486235-C6E3387B-9B91-4B43-8B6B-DD834F4D60D4Q34980529-E1F20B9C-B9A4-4C49-8BB4-420F2022B152Q35011884-C2618D60-D145-433E-883B-28DC48072B88Q35149536-A9320824-32B1-41B9-8098-D713463C10B8Q35212300-6FBCB733-C321-4B55-BF93-D2121A16FC9FQ35538600-2E1AA049-59D0-4A75-A1A2-A9057A16B3ABQ35779447-A313EC18-E69C-42E2-8AB5-71189C7F05F7Q35848853-F6A8F8CC-F0D6-4859-9773-20B3846A6621Q35853122-DE4B6797-53EA-418B-AC83-7943F62FBEC1Q35947839-08AE2CDE-70EF-4461-9725-4A784E8D4270Q36356594-C682B0D0-C1DA-42CA-BA72-9350B23576B9Q36411789-93BCDB33-159B-45E8-BDF2-79AF318A4657Q36623143-48611CA0-C21A-498B-ADBF-9596D6CC8B38Q36864497-3253DBFE-9141-4C65-B533-8C3E7129BBE6Q37212766-DDE96D23-48D6-417B-A828-C9B88042CEB9Q37300966-757960A3-8095-4086-8BD9-820C5F0C2EA2Q37367228-3DAA0998-E974-44D9-936C-0D156978FD95Q37381601-E498DA1F-CD20-46E6-9FE8-D6402677EB28
P2860
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@ast
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@en
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@nl
type
label
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@ast
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@en
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@nl
prefLabel
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@ast
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@en
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@nl
P2093
P2860
P3181
P1476
Mitochondrial dysfunction and ...... ng pathways to clinical trials
@en
P2093
Bradley J Behnke
Christiaan Leeuwenburgh
Maria Lorenzi
Matteo Cesari
Thomas W Buford
P2860
P304
P3181
P356
10.1016/J.BIOCEL.2013.06.024
P407
P577
2013-07-08T00:00:00Z